Company intelligence / Profile preview

Stevenage Bioscience Catalyst

Stevenage, Hertfordshire, United Kingdomstevenagecatalyst.com ↗

Ownership: Private
Employees: ~49
Development stage: Other

Overview

Stevenage Bioscience Catalyst serves as the UK’s first open innovation bioscience campus. It provides incubator and accelerator space for early-stage to established life sciences organizations focused on advanced therapeutics. Since opening in 2012, it has supported over £3.6 billion in equity investment raised by its resident companies. It plays a central role in the UK's cell and gene therapy cluster.

Modalities: Small moleculeBiologicCell therapyGene therapyMonoclonal antibodyDiagnostics/Devices
Industry: Drug Discovery Services

Partnerships

GlaxoSmithKline (GSK)Wellcome TrustInnovate UK/BEIS

Beyond the preview

Go deeper on Stevenage Bioscience Catalyst.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stevenage Bioscience Catalyst.

Explore the full profile